Accumulating data suggest that new cardiomyocytes in adults are generated from existing cardiomyocytes throughout life. To enhance the endogenous cardiac regeneration, we performed chemical screenings to identify compounds that activate pro-proliferative YES-associated protein and transcriptional enhancer factor domain activities in cardiomyocytes. We synthesized a novel fluorine-containing TT-10 (C11H10FN3OS2) from the biologically hit compound. TT-10 promoted cardiomyocyte proliferation and simultaneously exerted antioxidant and antiapoptotic effects in vitro. TT-10 treatment in mice ameliorated myocardial infarction-induced cardiac dysfunction at least in part via enhancing clonal expansion of existing cardiomyocytes with nuclear YES-associated protein expression. Stimulating cardiomyocyte proliferation and/or protection with TT-10 might complement current therapies for myocardial infarction.
Keywords: BIO, (2ʹZ,3ʹE)-6-bromoindirubin-3ʹ-oxime; EdU, 5-ethynyl-2ʹ-deoxyuridine; FGF1, acidic fibroblast growth factor; Hippo pathway; MI, myocardial infarction; NRF2, nuclear factor erythroid 2-related factor 2; NRG1, neuregulin-1; TAZ, transcriptional coactivator with PDZ-binding motif; TEAD, transcriptional enhancer factor domain; Wnt/β-catenin signaling; YAP, YES-associated protein; antioxidation; myocardial infarction; regeneration.